HSP inhibitors, in particular, appear to function overwhelmingly as chemosensitizers, modulating stress response pathways and disrupting protein homeostasis in cancer cells, thereby rendering them more susceptible to certain treatments. The gene discussed is HSP90B2P; the disease is cancer.